|

INX-315 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Incyclix Bio1

Indications

  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast1
  • CCNE1 Amplification1
  • Hormone Receptor Positive Tumor1
  • Advanced Cancer1
  • Breast Cancer, Metastatic1

Lake Mary, Florida1 trial

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Florida Cancer Specialists

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.